long term health effects of glp 1 GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment New Research on GLP-1s &
Description
10.1016/j.euroneuro.2024.02.003 52 HaldenT
This retrospective cohort study aims to explore the potential impact of GLP-1 receptor agonist use on urinary outcomes in non-diabetic patients with refractory OAB undergoing onabotulinumtoxinA treatment, addressing a critical gap in the current literature

meta-analysis: OR = 0.55, 95% CI [0.320.93])

Glucagonlike peptide1, but not glucosedependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

Safety and tolerability will also be evaluated.
